Add-On Daratumumab Triples Complete Response Rate in AL Amyloidosis
NEW YORK (Reuters Health) – Adding daratumumab to conventional therapy with cyclophosphamide, bortezomib and dexamethasone (CyBorD) nearly triples the rate
Read more
Curcumin for amyloidosis and lipid metabolism—a novel insight
Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many
Read more